Does low-dose aspirin reduce the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)?
The ATTACK trial has now finished recruitment. The study aimed to see whether or not patients with chronic kidney disease (CKD) should take aspirin daily to prevent a first heart attack or stroke. It has recruited over 4500 people with CKD from GP practices across the UK.
